Is Ryan Specialty Holdings (RYAN) Undervalued Following Its Q2 Earnings Beat?

Ryan Specialty Holdings, Inc. Class A

Ryan Specialty Holdings, Inc. Class A

RYAN

0.00

Ryan Specialty Holdings (RYAN) just reported second quarter 2026 results, combining revenue growth, a beat on analyst EPS estimates, an affirmed dividend, active buybacks, and a renewed focus on acquisition opportunities.

Ryan Specialty Holdings shares trade at US$44.60 after a 51.75% 90 day share price return, although the year to date share price return is down 11.88% and the 1 year total shareholder return is down 21.9%. This suggests recent momentum has picked up following earlier weakness as investors react to the earnings beat, dividend affirmation, buybacks, and renewed M&A focus.

If Ryan Specialty’s recent move has you looking for other opportunities, this could be a useful moment to scan the market using our screener of 19 top founder-led companies

After a 52% three month rebound yet a weaker year long return, Ryan Specialty Holdings now sits in a tricky spot. Is this the moment to commit fresh capital, or does it pay to wait for a better entry as the valuation stacks up next?

Most Popular Narrative: 2.8% Undervalued

Ryan Specialty Holdings closed at $44.60 compared with a narrative fair value of $45.88, which frames the recent rebound against only a modest estimated discount.

The analysts have a consensus price target of $45.88 for Ryan Specialty Holdings based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $76.0, and the most bearish reporting a price target of just $34.0.

Analysts are incorporating expectations of profit expansion and a richer future earnings multiple for Ryan Specialty Holdings. This raises questions about which growth and margin assumptions support that modest premium.

Result: Fair Value of $45.88 (UNDERVALUED)

However, Ryan Specialty Holdings still faces soft commercial pricing and integration risks from ongoing acquisitions, which could pressure margins and challenge the current undervalued narrative.

Another View On Ryan Specialty Holdings Valuation

The analyst fair value narrative suggests Ryan Specialty Holdings is about 2.8% undervalued at $44.60. The SWS DCF model points in a different direction. It estimates future cash flows support a value closer to $27.19, which implies the stock screens as expensive on that basis.

That is a wide gap between an earnings based fair value near $45.88 and a cash flow based value in the high $20s. For your own framework, consider which matters more right now: the earnings profile or the cash flow profile, and how much valuation risk you are willing to take on that difference.

RYAN Discounted Cash Flow as at Aug 2026
RYAN Discounted Cash Flow as at Aug 2026

Next Steps

With sentiment on Ryan Specialty Holdings split between opportunity and caution, this is a good time to look through the data yourself and decide quickly where you stand. To weigh both sides of the story in one place, start by reviewing the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Ryan Specialty Holdings?

If Ryan Specialty Holdings has sharpened your focus on valuation and risk, do not stop here. Use this window to broaden your watchlist before the next move.

  • Spot potential turnaround stories early by reviewing 20 elite penny stocks with strong financials that already show stronger financial footing than many peers.
  • Target value driven opportunities by scanning the 52 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect them.
  • Prioritize resilience and sleep at night holdings by focusing on companies in the 82 resilient stocks with low risk scores that score well on balance sheet strength and risk checks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.